Imiquimod treatment for lentigo maligna: LIMIT-1 trial
- PMID: 28369728
- DOI: 10.1111/bjd.15511
Imiquimod treatment for lentigo maligna: LIMIT-1 trial
Comment on
-
Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study.Br J Dermatol. 2017 May;176(5):1148-1154. doi: 10.1111/bjd.15112. Epub 2017 Apr 10. Br J Dermatol. 2017. PMID: 27714781 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
